Neuroendocrine tumor of the uterine cervix: a clinicopathologic study of 14 cases
- 638 Downloads
The study explored the clinicopathologic characteristics of the neuroendocrine tumor of uterine cervix (NTUC).
The general information and the clinical–pathological characteristics of 14 NTUC cases were reviewed.
The median age of the cases was 41 years. Six cases (42.9 %) were FIGO stage Ib1, four cases (28.6 %) were Ib2, one case was IIa2 (7.1 %), one case (7.1 %) was IIb, one case (7.1 %) was IIIb and one case (7.1 %) was IVb. Radical hysterectomy and bilateral salpingo-oophorotomy plus pelvic lymphadenectomy were performed on seven cases: three cases had radical hysterectomy plus pelvic lymphadenectomy; one case had transabdominal hysterectomy; and one case had a residual cervical resection. Four cases had positive pelvic lymph nodes. Two cases (14.3 %) had the tumor infiltrated to the parametrium and five cases (35.7 %) to lymphovascular space. One case had positive margin of vagina. Nine cases (64.3 %) were administered post-surgery radiotherapy and all cases were given adjuvant chemotherapy. The median follow-up time was 10 months. The median disease-free survival was 6 months, and the median total survival time was 18 months. The median estimated survival time was 32.0 months (95 % CI 16.9–47.1 months).
NTUC is a very rare malignant tumor of female genital tract. Multi-center cooperation to gather more cases is the best method to explore the biological behavior and for the proper treatment of NTUC.
KeywordsNeuroendocrine Carcinoma Cervix Prognosis Treatment
Conflict of interest
We declare that we have no conflict of interest.
- 2.Albores-Saavedra J, Gersell D, Gilks CB, Henson DE, Lindberg G, Santiago H, Scully RE, Silva E, Sobin LH, Tavassoli FJ, Travis WD, Woodruff JM (1997) Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med 121(1):34–39PubMedGoogle Scholar
- 3.Albores- Saavedra J, Poucell S, Rodriguez- Martinez HA (1972) Primary carcinoid of the uterine cervix. Patologia 10:185–193Google Scholar
- 9.Ishida GM, Kato N, Hayasaka T, Saito M, Kobayashi H, Katayama Y, Sasou S, Yaegashi N, Kurachi H, Motoyama T (2004) Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study. Int J Gynecol Pathol 23(4):366–372 [pii: 00004347-200410000-00009]PubMedCrossRefGoogle Scholar
- 17.Lee JM, Lee KB, Nam JH, Ryu SY, Bae DS, Park JT, Kim SC, Cha SD, Kim KR, Song SY, Kang SB (2008) Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study. Ann Oncol 19(2):321–326. doi: 10.1093/annonc/mdm465 PubMedCrossRefGoogle Scholar
- 21.Chang TC, Lai CH, Tseng CJ, Hsueh S, Huang KG, Chou HH (1998) Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer 83(4):712–718. doi: 10.1002/(SICI)1097-0142(19980815)83:4<712::AID-CNCR12>3.0.CO;2-V PubMedCrossRefGoogle Scholar
- 25.Tangjitgamol S, Manusirivithaya S, Choomchuay N, Leelahakorn S, Thawaramara T, Pataradool K, Suekwatana P (2007) Paclitaxel and carboplatin for large cell neuroendocrine carcinoma of the uterine cervix. J Obstet Gynaecol Res 33(2):218–224. doi: 10.1111/j.1447-0756.2007.00509.x PubMedCrossRefGoogle Scholar
- 27.Hoskins PJ, Swenerton KD, Pike JA, Lim P, Aquino-Parsons C, Wong F, Lee N (2003) Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 21(18):3495–3501. doi: 10.1200/JCO.2003.01.501 PubMedCrossRefGoogle Scholar